All posts by: Jocelyn Cao

About Jocelyn Cao

Read the full press release here An Advocate Aurora Health research scientist was one of 42 grant awardees selected to participate in a prestigious national data-sharing mentoring program designed to improve community health. Now in its fifth year, Data Across Sectors for Health (DASH) forms collaborations between health care, public health, social services, housing, education, […]

Read the full press release here Pharmaceutical Research and Manufacturers of America president and CEO, Stephen J. Ubl issued the following statement: “This week, the Advisory Committee on Immunization Practices (ACIP) met to consider the prioritization of which communities should receive the initial doses of vaccines to prevent COVID-19 infection should the U.S. Food and […]

Read the full press release here University of Wisconsin System nursing students will have a new opportunity to fight the COVID-19 pandemic while earning valuable experience and a tuition credit, System President Tommy Thompson announced today. Through the winter break, the System’s approximately 4,000 nursing students will be able to earn experience and a $500 […]

Read the full press release here The study of all proteins in a biological system, or proteomics, enables an unbiased assessment of protein quantities. Proteome analysis is an important tool for clinicians and biologists to build hypotheses about how protein changes are associated with disease, which can lead to new therapeutics. Proteomics technology continues to […]

Read the full press release here GE Healthcare today announced a new artificial intelligence (AI) algorithm to help clinicians assess Endotracheal Tube (ETT) placements, a necessary and important step when ventilating critically ill COVID-19 patients. The AI solution is one of five included in GE Healthcare’s Critical Care Suite 2.02, an industry-first collection of AI […]

Read the full press release here Advocate Aurora Health recently joined a clinical trial evaluating the role of a presurgical screening and care model, or toolkit, in improving surgical care and outcomes in older patients with cancer. The study, “Use of a pre-surgical toolkit in improving surgical care and outcomes in older participants with cancer,” […]

Read the full press release here WASHINGTON, D.C. (November 17, 2020) – Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced first-ever, industry-wide principles on clinical trial diversity. The principles focus on four main areas: building trust and acknowledging the historic mistrust of clinical trials within Black and Brown communities, reducing barriers to clinical […]